Market Tracker

06/26 11:35am ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

32.88
BATS BZX Real-Time Price
As of 11:35am ET
 +0.27 / +0.83%
Today’s Change
27.60
Today|||52-Week Range
56.44
-9.30%
Year-to-Date
Allergan Continues to Focus on Acquisitions and Branded Unit
9:52am / Zacks.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Teva Ready for Higher Prices
Jun 23 / TheStreet.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close32.61
Today’s open32.84
Day’s range32.78 - 33.40
Volume189,274
Average volume (3 months)7,741,731
Market cap$33.1B
Dividend yield4.14%
Data as of 11:35am ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-6.33%
Earnings growth (next 5 years)+0.35%
Revenue growth (last year)+12.01%
P/E ratio1,645.5
Price/Sales1.59
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.39-0.87%
OASMOasmia Pharmaceutica...-0.03-2.73%
Data as of 11:16am ET, 06/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$1.13
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts